1. Home
  2. BCTX vs VVOS Comparison

BCTX vs VVOS Comparison

Compare BCTX & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCTX
  • VVOS
  • Stock Information
  • Founded
  • BCTX 2014
  • VVOS 2016
  • Country
  • BCTX Canada
  • VVOS United States
  • Employees
  • BCTX N/A
  • VVOS N/A
  • Industry
  • BCTX Biotechnology: Pharmaceutical Preparations
  • VVOS Medical Specialities
  • Sector
  • BCTX Health Care
  • VVOS Health Care
  • Exchange
  • BCTX Nasdaq
  • VVOS Nasdaq
  • Market Cap
  • BCTX 18.5M
  • VVOS 19.4M
  • IPO Year
  • BCTX N/A
  • VVOS 2020
  • Fundamental
  • Price
  • BCTX $8.20
  • VVOS $2.22
  • Analyst Decision
  • BCTX Strong Buy
  • VVOS Strong Buy
  • Analyst Count
  • BCTX 1
  • VVOS 2
  • Target Price
  • BCTX $40.00
  • VVOS $6.75
  • AVG Volume (30 Days)
  • BCTX 45.4K
  • VVOS 127.9K
  • Earning Date
  • BCTX 12-15-2025
  • VVOS 11-19-2025
  • Dividend Yield
  • BCTX N/A
  • VVOS N/A
  • EPS Growth
  • BCTX N/A
  • VVOS N/A
  • EPS
  • BCTX N/A
  • VVOS N/A
  • Revenue
  • BCTX N/A
  • VVOS $17,317,000.00
  • Revenue This Year
  • BCTX N/A
  • VVOS $19.45
  • Revenue Next Year
  • BCTX N/A
  • VVOS $70.80
  • P/E Ratio
  • BCTX N/A
  • VVOS N/A
  • Revenue Growth
  • BCTX N/A
  • VVOS 18.76
  • 52 Week Low
  • BCTX $6.00
  • VVOS $1.98
  • 52 Week High
  • BCTX $190.50
  • VVOS $7.95
  • Technical
  • Relative Strength Index (RSI)
  • BCTX 36.92
  • VVOS 36.52
  • Support Level
  • BCTX $6.93
  • VVOS $2.30
  • Resistance Level
  • BCTX $11.54
  • VVOS $2.50
  • Average True Range (ATR)
  • BCTX 0.78
  • VVOS 0.19
  • MACD
  • BCTX -0.39
  • VVOS 0.00
  • Stochastic Oscillator
  • BCTX 22.77
  • VVOS 19.35

About BCTX BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: